A landmark national study led by researchers at NYU Langone Health has revealed a staggering gap in the kidney transplant pipeline, finding that nearly half of all patients referred for transplantation never even begin the evaluation process. The research, published in the Journal of the American Society of Nephrology and presented at the American Transplant Congress, analyzed data from more than 720,000 patients and represents the most comprehensive examination to date of where patients fall out of the transplant continuum.
The findings paint a stark picture of systemic failure. Of the 720,348 patients tracked in the study, 48 percent never initiated a single step toward evaluation at a transplant center. Only 19 percent of referred patients completed the full evaluation and were ultimately placed on the transplant waiting list. The remaining patients dropped out at various intermediate stages, suggesting that barriers to transplantation arise long before patients reach the surgical table.
Researchers identified several demographic and geographic factors strongly associated with lower chances of progressing through evaluation. Patients who were unmarried, had severe obesity, or lived in rural communities were significantly less likely to start or complete the process. Older adults, Spanish-speaking patients, and those with lower household incomes faced especially steep obstacles. Programs located in the Southern United States and smaller transplant centers also showed markedly lower rates of patient progression.
The study underscores deep-rooted racial and socioeconomic disparities in organ transplant access that have persisted for decades despite targeted policy reforms. Previous research has shown that Black patients are 13 percent less likely to be listed for transplantation and face a 39 percent lower likelihood of receiving a transplant compared to White patients. Contributing factors include reduced healthcare access, knowledge gaps, provider biases, transportation barriers, and housing and food insecurity that disproportionately affect minority communities.
Kidney failure affects more than 800,000 people in the United States, and transplantation is widely considered the gold standard treatment, offering better survival rates and quality of life compared to long-term dialysis. Yet the gap between referral and waitlisting means that hundreds of thousands of eligible patients are effectively shut out of the process each year. Experts say the problem requires a fundamental rethinking of how transplant centers engage with referred patients.
The researchers called for systemic interventions including streamlined evaluation processes, enhanced outreach to underserved populations, and the development of patient navigation programs designed to guide individuals through each step of the transplant evaluation. They also recommended that transplant centers invest in telehealth consultations and community-based education to reduce geographic and financial barriers that prevent patients from completing their evaluations.
Health policy advocates have described the findings as a call to action, arguing that addressing these pre-waitlist barriers could significantly increase the number of patients who ultimately receive life-saving transplants. The study adds urgency to ongoing national conversations about organ donation reform and equitable healthcare access, with several medical organizations now calling for standardized evaluation protocols across all transplant programs in the country.
Comments